Insight Guide
A Structured Approach to Enhancing Bioavailability for Early Development Phase Molecules
Drug development cost, lengthier development cycles, and identifying a suitable delivery platform were identified as the top three business challenges by formulation scientists and R&D managers in a recent survey. Recent strides in drug development tools make them a great resource for formulation scientists but as the nature of the drug molecule becomes more complex, a single tool used in silo cannot solve all the challenges.
